Suppr超能文献

探讨 2 型糖尿病(T2DM)和肥胖症中骨健康的动物模型综述。

A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.

机构信息

The Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.

Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA, Sg Buloh 47000, Malaysia.

出版信息

Int J Mol Sci. 2024 Aug 29;25(17):9399. doi: 10.3390/ijms25179399.

Abstract

Preclinical research on diabetes and obesity has been carried out in various animal models over the years. These animal models are developed from genetic manipulation that affects their body metabolism, chemical-induced procedures, diet alteration/modifications, or combinations of the aforementioned approaches. The diabetic and obesity animal models have allowed researchers to not only study the pathological aspect of the diseases but also enable them to screen and explore potential therapeutic compounds. Besides several widely known complications such as macrovascular diseases, diabetic neuropathy, nephropathy and retinopathy, type 2 diabetes mellitus is also known to affect bone health. There is also evidence to suggest obesity affects bone health. Therefore, continuous research needs to be conducted to find a remedy or solution to this matter. Previous literature reported evidence of bone loss in animal models of diabetes and obesity. These findings, as highlighted in this review, further augment the suggestion of an inter-relationship between diabetes, obesity and bone loss.

摘要

多年来,糖尿病和肥胖症的临床前研究一直在各种动物模型中进行。这些动物模型是通过影响其身体代谢的基因操作、化学诱导程序、饮食改变/修改或上述方法的组合开发的。糖尿病和肥胖动物模型不仅使研究人员能够研究疾病的病理方面,还使他们能够筛选和探索潜在的治疗化合物。除了几种众所周知的并发症,如大血管疾病、糖尿病神经病变、肾病和视网膜病变外,2 型糖尿病还已知会影响骨骼健康。有证据表明肥胖也会影响骨骼健康。因此,需要持续进行研究,以找到解决这一问题的方法。以前的文献报道了糖尿病和肥胖动物模型中骨丢失的证据。正如本综述所强调的那样,这些发现进一步增加了糖尿病、肥胖症和骨丢失之间存在相互关系的观点。

相似文献

1
A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.
Int J Mol Sci. 2024 Aug 29;25(17):9399. doi: 10.3390/ijms25179399.
2
Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models.
Peptides. 2024 Jul;177:171228. doi: 10.1016/j.peptides.2024.171228. Epub 2024 Apr 23.
3
Nutritional Models of Type 2 Diabetes Mellitus.
Methods Mol Biol. 2020;2076:43-69. doi: 10.1007/978-1-4939-9882-1_3.
4
Potential Functions of the BMP Family in Bone, Obesity, and Glucose Metabolism.
J Diabetes Res. 2021 Jun 23;2021:6707464. doi: 10.1155/2021/6707464. eCollection 2021.
5
Path of translational discovery of urological complications of obesity and diabetes.
Am J Physiol Renal Physiol. 2017 May 1;312(5):F887-F896. doi: 10.1152/ajprenal.00489.2016. Epub 2017 Jan 4.
6
The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis.
Front Endocrinol (Lausanne). 2023 Jul 20;14:1168687. doi: 10.3389/fendo.2023.1168687. eCollection 2023.
7
Porcine models for studying complications and organ crosstalk in diabetes mellitus.
Cell Tissue Res. 2020 May;380(2):341-378. doi: 10.1007/s00441-019-03158-9. Epub 2020 Jan 13.
8
The Impact of Exercise on Bone Health in Type 2 Diabetes Mellitus-a Systematic Review.
Curr Osteoporos Rep. 2020 Aug;18(4):357-370. doi: 10.1007/s11914-020-00597-0.
9
Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.
Curr Diabetes Rev. 2014 Mar;10(2):131-45. doi: 10.2174/1573399810666140508121012.
10
Beta-cell function and mass in type 2 diabetes.
Dan Med Bull. 2009 Aug;56(3):153-64.

引用本文的文献

1
Types of cell death in diabetic cardiomyopathy: insights from animal models.
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 25;57(5):681-689. doi: 10.3724/abbs.2024213.

本文引用的文献

1
Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target.
Int J Mol Sci. 2024 Apr 28;25(9):4827. doi: 10.3390/ijms25094827.
5
Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats.
Int J Mol Sci. 2023 Jan 19;24(3):1991. doi: 10.3390/ijms24031991.
6
7
IL-1β promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells.
J Pharmacol Sci. 2023 Jan;151(1):1-8. doi: 10.1016/j.jphs.2022.10.007. Epub 2022 Oct 21.
8
Ginsenoside compound K increases glucagon-like peptide-1 release and L-cell abundance in db/db mice through TGR5/YAP signaling.
Int Immunopharmacol. 2022 Dec;113(Pt A):109405. doi: 10.1016/j.intimp.2022.109405. Epub 2022 Nov 9.
9
Effects of Isoprenaline on ventricular myocyte shortening and Ca transport in the Zucker rat.
Eur J Pharmacol. 2022 Oct 15;933:175263. doi: 10.1016/j.ejphar.2022.175263. Epub 2022 Sep 12.
10
Hyperinsulinemia induces early and dyssynchronous puberty in lean female mice.
J Endocrinol. 2022 Aug 9;254(3):121-135. doi: 10.1530/JOE-21-0447. Print 2022 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验